WW International Q3 revenue falls 10.8%, narrows 2025 guidance

WW International

06/11/2025 12:17

Overview

WW International Q3 revenue declined 10.8% yr/yr

Clinical Subscription Revenue grew 35% yr/yr, reflecting strong retention

Company narrows 2025 guidance to higher end for revenue and adjusted EBITDA

Outlook

Company narrows 2025 revenue guidance to $695 mln - $700 mln

Company narrows 2025 adjusted EBITDA guidance to $145 mln - $150 mln

Result Drivers

CLINICAL REVENUE GROWTH - Clinical Subscription Revenue increased 35% yr/yr due to strong retention of members using compounded semaglutide

DEBT REDUCTION - Co reduced total debt by over 70% post-restructuring, strengthening balance sheet

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
Q3 Revenue
$172 mln


Press Release: ID:nGNXbL53gc

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)